Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Memorial Sloan-Kettering Cancer Centre (MSKCC/Motzer) score

MD Maeva Dufies
SG Sandy Giuliano
JV Julien Viotti
DB Delphine Borchiellini
LC Linsay S Cooley
DA Damien Ambrosetti
MG Mélanie Guyot
PN Papa Diogop Ndiaye
JP Julien Parola
AC Audrey Claren
RS Renaud Schiappa
JG Jocelyn Gal
AF Antoine Frangeul
AJ Arnaud Jacquel
OC Ophélie Cassuto
RG Renaud Grépin
PA Patrick Auberger
AB Andréas Bikfalvi
GM Gérard Milano
BE Bernard Escudier
NR Nathalie Rioux-Leclercq
CP Camillo Porta
SN Sylvie Negrier
EC Emmanuel Chamorey
JF Jean-Marc Ferrero
GP Gilles Pagès
request Request a Protocol
ask Ask a question
Favorite

Memorial Sloan-Kettering Cancer Centre score predicts survival based on clinical and laboratory data in metastatic RCC patients. It is a combination of: (1) performance status (Karnofsky score)<80%, (2) time from diagnosis to systemic treatment<12 months, (3) haemoglobin less than the lower limit of normal, (4) lactate dehydrogenase>1.5 × upper limit of normal, (5) corrected calcium>10 mg dl−1 (2.5 mmol l−1). Score 0, 1–2 or ⩾3 corresponding respectively to Good, Intermediate or Bad Risk Group (Motzer et al, 1999).

Copyright and License information:  ©2017 Cancer Research UK
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A